Omeros Corp (OMER)
3.44
+0.02
(+0.58%)
USD |
NASDAQ |
Mar 28, 16:00
3.44
0.00 (0.00%)
After-Hours: 20:00
Omeros Enterprise Value: 222.68M for March 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 28, 2024 | 222.68M |
March 27, 2024 | 221.43M |
March 26, 2024 | 223.94M |
March 25, 2024 | 222.68M |
March 22, 2024 | 220.17M |
March 21, 2024 | 237.14M |
March 20, 2024 | 243.43M |
March 19, 2024 | 232.11M |
March 18, 2024 | 227.71M |
March 15, 2024 | 235.89M |
March 14, 2024 | 237.77M |
March 13, 2024 | 260.40M |
March 12, 2024 | 259.78M |
March 11, 2024 | 270.46M |
March 08, 2024 | 281.78M |
March 07, 2024 | 290.58M |
March 06, 2024 | 283.66M |
March 05, 2024 | 271.09M |
March 04, 2024 | 285.55M |
March 01, 2024 | 306.92M |
February 29, 2024 | 289.32M |
February 28, 2024 | 291.21M |
February 27, 2024 | 289.32M |
February 26, 2024 | 292.46M |
February 23, 2024 | 265.43M |
Date | Value |
---|---|
February 22, 2024 | 267.63M |
February 21, 2024 | 272.98M |
February 20, 2024 | 299.38M |
February 16, 2024 | 313.84M |
February 15, 2024 | 313.84M |
February 14, 2024 | 294.35M |
February 13, 2024 | 234.63M |
February 12, 2024 | 252.55M |
February 09, 2024 | 246.57M |
February 08, 2024 | 214.51M |
February 07, 2024 | 213.25M |
February 06, 2024 | 217.03M |
February 05, 2024 | 212.63M |
February 02, 2024 | 220.17M |
February 01, 2024 | 220.17M |
January 31, 2024 | 210.11M |
January 30, 2024 | 212.63M |
January 29, 2024 | 217.03M |
January 26, 2024 | 213.25M |
January 25, 2024 | 217.03M |
January 24, 2024 | 223.63M |
January 23, 2024 | 220.80M |
January 22, 2024 | 232.11M |
January 19, 2024 | 250.97M |
January 18, 2024 | 249.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
74.32M
Minimum
Oct 27 2023
1.552B
Maximum
Feb 19 2021
686.12M
Average
736.09M
Median
Dec 10 2021
Enterprise Value Benchmarks
Aspira Womens Health Inc | 385.14M |
Harrow Inc | 567.19M |
Ardelyx Inc | 1.564B |
Ensysce Biosciences Inc | 5.165M |
MAIA Biotechnology Inc | 36.86M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -37.75M |
Total Expenses (Quarterly) | 48.15M |
EPS Diluted (Quarterly) | -0.60 |
Earnings Yield | 9.30% |
Normalized Earnings Yield | -64.22 |